[Patient and quality characteristics in the treatment with disulfiram (Antabus) in the German "Network for Alcohol Aversive Pharmacotherapy"].

ABSTRACT:

Background

More than a decade ago disulfiram lost its approval for use in Germany. Nonetheless, a considerable number of psychiatric hospital outpatient departments as well as practicing physicians continue to prescribe it. These professionals have formed the "Network for Alcohol Aversive Pharmacotherapy" (NAP) to maintain a high quality of this treatment approach.

Objective

To describe the current use of disulfiram with respect to patient numbers and characteristics, side effects, and use of concomitant multimodal treatment forms.

Material and methods

Since 2019 the NAP has conducted an annual retrospective survey among its members regarding the aforementioned parameters.

Results

From 2019 to 2023 a total of 1579 treatment cases were described by 33 centers, 1

SUBMITTER: Zimmermann US 

PROVIDER: S-EPMC11876189 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature